CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −775 | $75.05 | $58K | 59,657 |
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Option exercise 10b5-1 | +905 | $56.78 | $51K | 60,562 |
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −905 | $75.05 | $68K | 59,657 |
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −905 | 15,538 | ||
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −775 | 19,101 | ||
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Option exercise 10b5-1 | +775 | $56.78 | $44K | 60,432 |
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −775 | $75.05 | $58K | 59,657 |
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Option exercise 10b5-1 | +905 | $60.89 | $55K | 60,562 |
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −905 | $75.05 | $68K | 59,657 |
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −775 | 15,668 | ||
| 2025-11-03 | Geary Richard S EVP, Chief Development Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −905 | 18,971 | ||
| 2025-10-31 | WENDER JOSEPH H Director | Sale 10b5-1 | −11,200 | $75.16 | $842K | 64,035 |
| 2025-10-31 | LOSCALZO JOSEPH Director | Option exercise 10b5-1 | +16,000 | $52.22 | $836K | 52,330 |
| 2025-10-31 | LOSCALZO JOSEPH Director | Sale 10b5-1 | −16,000 | $75.10 | $1.2M | 36,330 |
| 2025-10-31 | LOSCALZO JOSEPH Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −16,000 | 0 | ||
| 2025-10-31 | Geary Richard S EVP, Chief Development Officer | Option exercise 10b5-1 | +34,585 | $60.89 | $2.1M | 114,242 |
| 2025-10-31 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −34,585 | $75.11 | $2.6M | 79,657 |
| 2025-10-31 | Geary Richard S EVP, Chief Development Officer | Option exercise 10b5-1 | +34,664 | $56.78 | $2.0M | 114,321 |
| 2025-10-31 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −34,664 | $75.11 | $2.6M | 79,657 |
| 2025-10-31 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −20,000 | $75.11 | $1.5M | 59,657 |
Page 20 of 34 · 668 trades